Antibodies that specifically bind to a beta oligomers and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8858949
APP PUB NO 20120177664A1
SERIAL NO

13389229

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present inventors successfully produced monoclonal antibodies that are specific to only soluble A beta oligomers, but do not recognize soluble A beta monomers, which are physiological molecules. It was demonstrated that the antibodies are useful as diagnostic/therapeutic monoclonal antibodies for Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMMUNAS PHARMA INCKANAGAWA SCIENCE PARK R&D D11F 3-2-1 SAKADO TAKATSU-KU KAWASAKI-SHI KANAGAWA 2130012

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fujii, Shinobu Kanagawa, JP 5 142
Imai, Yukiho Kanagawa, JP 6 140
Ito, Toshiyuki Kanagawa, JP 84 857
Okamoto, Yasuhide Kanagawa, JP 7 169
Takamatsu, Naofumi Kanagawa, JP 3 140
Umeda, Makoto Kanagawa, JP 21 425
Yokoseki, Tatsuki Kanagawa, JP 10 205

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 14, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00